Author Archive Solchem

The importance of the second brain

Gut health has an importance that goes beyond the digestive and assimilation processes carried out on it. There is more and more evidence of its importance in the development of diseases that apparently are far from what happens in the intestine. Given the importance of proper intestinal health for the maintenance of general health, the gut is also known as the second brain.

In our gut cohabits a bacterial flora that is known as microbiota. We have more than 100 trillion bacteria (1×1014), which are not equally distributed throughout the gastrointestinal tract. They pass from 10 to 1000 bacteria per gram in the stomach to more than 1 trillion per gram in the intestine (1×1012). In fact, we have 10 times more bacteria than cells in our body. In addition, these bacteria have their own genes that represent 100 times the total human genes. The term microbioma refers to this set of genes present in the microorganisms that inhabit our gastrointestinal tract.

Despite bacterial flora is specific to each person, it can be said that these bacteria are distributed in 150 species of the more than 1000 species that may be present. This bacterial diversity is important for our health.

Increase in the number of bacteria along the intestinal tract

How does the microbiota behave on our body?

Under normal conditions, the bacteria are placed on the mucosa of the intestinal epithelium and does not penetrate into the body. However, contrary to what most people think, the gut microflora has an influence that extends beyond the intestinal lumen.

The intestinal microflora acts on three levels:

• Level 1: Bacteria – bacteria interaction
• Level 2: Bacteria – intestinal mucosa interaction
• Level 3: Bacteria – host immune system interaction.

At the first level, bacteria interact with other bacteria, either beneficial as pathogenic. At this level, the beneficial bacteria and commensal establish symbiotic relationships with other, but also release important substances such as lactic acid and bacteriocins that allow them to control and compete with the pathogenic flora.

At the second level, the microflora initiates the interaction with the host throughout the intestinal microvilli. In this sense, bacteria establish recognition between the lipopolysaccharides present in the bacterial wall with the receptors present in the membrane of the enterocytes. This recognition is very important because it allows the creation of beneficial interactions with immune intestinal cells and allows the maintenance of mucosa integrity.

At the third level, bacteria contact with the host immune system, thanks to the presence of the dendritic cells located in the basal part of the intestinal mucosa. Dendritic cells are the most powerful antigen presenting cells and control the type of immune response to be established (pro-inflammatory or regulatory), as well as its location after making antigen presentation.

Dendritic cells are, therefore, very efficient in controlling the delicate balance between tolerance and immunity in an environment exposed to a huge quantity of antigens as intestines are. Any factor affecting dendritic cells activity can have an impact on its functionality, even in the development of intestinal pathologies like celiac disease or inflammatory bowel disease.

Dysbiosis: microbiota disorder

Several factors can alter the presence, concentration, distribution and type of bacteria that inhabit our intestine. Situations such as malnutrition or unbalanced nutrition, antibiotic consumption or stress can lead to an imbalanced flora situation known as dysbiosis that facilitates the onset of diseases.

On the left an intestinal mucosa with proper bacterial flora and on the right an intestinal mucosa suffering dysbiosis.

Both, the World Health Organization (WHO) and the Food and Agriculture Organization of the United Nations (FAO), recognize that the alteration of the intestinal flora leads to the occurrence of diseases that are directly related to the gut, but also diseases or conditions indirectly related to it:

Directly related to the Intestine:

• Diarrhoea
• Antibiotic associated diarrhoea
• Traveler’s diarrhoea
• Infantile diarrhoea (rotavirus)
• Diarrhoea caused by food pathogens
• Constipation
• Irritable Bowel Syndrome (IBS)
• Intestinal inflammation
• Helicobacter pylori infection

Indirectly related to the Intestine:

• Allergy
• Cancer
• Cardiovascular disease
• Urinary tract infections
• Bacterial vaginosis
• Autism
• Hepatic cirrhosis
• Migraine
• Depression

Action at Level 3: immunomodulation

The immune system consists of several interdependent cells that collectively protect the body against the aggression of pathogenic microorganisms, parasites and viruses. The intestinal microflora plays an important role in the correct function of the immune system and the research carried out in this respect has shown that probiotics can modulate this aspect.

It is known that probiotics can act on the immune system of the host by signals sent from the intestinal lumen by dendritic cells, which stimulate CD4+ T cells that can lead to different populations of regulatory T cells (Treg).

Regulatory T cells are the main elements in maintaining the balance between the two populations of T helper (Th1/Th2) and, also, are responsible for maintaining the homeostasis of the immune system by secretion of IL-10.

In this regard, is important to say that all the strains present in Megaflora 9 evo have demonstrated its ability to interact with the immune system. Some of them stand out for their capacity to increase the production of IL-10, a regulatory and anti-inflammatory cytokine.

Example of mechanism regulating the host immunity by Lactobacillus plantarum W1 through interaction of dendritic cells.

Next graph shows the induction of IL-10 by different strains of Megaflora 9 evo in the presence of peripheral mononuclear blood cells. From the different tested strains, Lactobacillus plantarum W21, L. acidophilus W22 and Enterococcus faecium W54, were those that presented a higher degree of stimulation, being E. faecium W54 the strain with the greatest potential in stimulating the production of IL-10.

Production of IL-10 in a culture of peripheral mononuclear blood cells in presence of different strains present in Megaflora 9 evo (Lactococcus lactis W19, L. paracasei W20, L. plantarum W21, L. acidophilus W22 and Enterococcus faecium W54).

Action at Level 2: influence on the epithelial barrier function

Maintaining intestinal homeostasis requires that the epithelium, a layer of cells lining the intestinal wall, keeps formeing an uninterrupted barrier without spaces or gaps between the enterocytes. This optimal situation is known as barrier effect.

Normally, in a healthy person there is a communication and control between the host and microbiota residing in the gut, which creates a homeostatic balance of bacterial flora by promoting the growth of beneficial bacteria, preventing overgrowth and controlling the development of pathogenic bacteria.

The phenomena of dysbiosis, or imbalance of intestinal flora, invariably lead to bacterial overgrowth of the small intestine called SIBO (Small Intestine Bacterial Overgrowth), which tilts the balance toward the growth of pathogenic bacteria.

It is also known that situations such as food intolerances, presence of allergens like gluten, digestive disorders and even lifestyle are factors that increase intestinal permeability, losing the integrity of the intestinal mucosa.

All these unfavourable conditions taken together lead to an imbalance in the intestine that causes an alteration in the absorption processes, with the consequent lack of nutrients and micronutrients in the body, essential for a healthy live and, in the more severe states, favours the passage of toxic substances into the body.

The damage caused by the intestinal imbalance not only cause situations such as irritable bowel syndrome or Crohn’s disease, but some scientific studies claim that high permeability of the intestine can be the cause of many mental and nervous illnesses, such as senile dementia, Alzheimer or Parkinson among others.

Megaflora 9 evo has demonstrated its ability to counter the phenomena of dysbiosis rebalancing the intestinal flora, maintaining the barrier effect and promoting the integrity of the gut mucosa, that allows the maintenance of the absorption processes and homeostasis between the host and the intestinal microbiota.

The integrity of the intestinal epithelium can be measured by an in vitro test that measures the Trans-Epithelial Electrical Resistance (TEER).

TEER methodology

TEER is a widely accepted quantitative technique that measures the dynamic integrity of cell junctions (tight junction) in models of endothelial and epithelial monolayers. TEER values are reliable indicators of the integrity of cell barriers for assessing the transport of drugs and other substances.

The values obtained in the TEER inform in real time reports about the integrity or alteration of monolayer cells, which is manifested by the electrical variation of values between the upper and the lower chambers. When the monolayer is subjected to the presence of a stressor in the apical part (upper chamber), the change in permeability can be measured as a decrease TEER between the upper and lower chamber.

The effectiveness of a probiotic strain on maintaining the barrier effect while placing the stressor can be detected by smaller decreases in TEER. The lesser decrease in TEER, the more effectiveness of the probiotic in maintaining the integrity of the monolayer and therefore it will preven the increase of permeability in presence of stressor agents.

TEER Methodology

To determine the barrier effect of Megaflora 9 evo, a Caco-2 monolayer cells was subjected to the presence of a stressor which increases the monolayer permeability.

The result showed that Megaflora 9 evo had a positive effect on the integrity of the monolayer cells, reducing the negative impact of the stressor compared to control.

Change in TEER in a monolayer of Caco-2 cells subjected to the presence of a stressor (red) and in the presence of the stressor and Megaflora 9 evo (green), relative to the control without stressor (blue)

Upon this result, it follows that the composition of Megaflora 9 evo has a balancing effect on the microflora in the intestine, avoiding the increased permeability of the intestinal mucosa caused by the presence of certain substances, pathogens or situations that influence the regulation of the bowel activity.

>> Action at Level 3: immunomodulation

Prevention and treatment of dysbiosis: characterization of probiotics

The WHO (World Health Organization) and the FAO (Food and Agriculture Organization of the United Nations) recommend the use of probiotics for preventing and treating disorders caused by an unbalanced microflora and advise the medical community to consider this application for preventive and therapeutic actions.

It is worth remembering what a probiotic is since, recently, it has been introduced in the food supplements market products that are sold as probiotics, which do not meet the definition given by WHO:

“A probiotic is a living microorganism which, when administered in adequate amounts, confers health benefits to the host”.

In order to classify bacteria as probiotic, it is necessary to provide enough documented scientific evidence on the beneficial health effects because not all bacteria have the same effectiveness, even belonging to the same genus and species. Hence, it is important a perfect characterization of bacterial strains, which allows a correct selection of probiotics.

Let’s take as an example a study on the degree of inhibition of Candida albicans by different individual strains of Bifidobacterium, Lactobacillus, Enterococcus and Lactococcus.

Percentage of inhibition of Candida albicans by different bacterial species and strains properly characterized.

The figure shows that of the 3 strains Bifidobacterium studied (two of B. bifidum and one of B. lactis), only the two strains of B. bifidum presented an inhibition of more than 30% of Candida, but only the strain characterized as B. bifidum W28 inhibited Candida more than 80% when compared to B. bifidum W23 strain.

This study demonstrates also that of the three characterized strains of Lactobacillus acidophilus used (W22, W55 and W74), the strain L. acidophilus W55 did not inhibit the growth of Candida, unlike the characterized strains W22 and W74 did.

Therefore, the characterization allows to highlight the properties of a bacteria, showing that the properties of bacteria X are different from bacteria Y. In addition, the use of well-characterized strains makes that the combination of different bacteria with different properties increase their effectiveness.

It conclusion, multi-strain and multispecies mixtures are much more beneficial than the use of individual bacteria, as these mixtures will act on the three levels of the intestine.

Action at Level 1: Inhibition of pathogenic

The capacity to inhibit a pathogen, either from a bacteria or a substance with antibiotic properties, is usually determined in vitro in a growth medium with agar in Petri dish, where the pathogen is growing and where the substance or bacteria to evaluate is placed.

This classical method is based on the presence of an inhibition zone around a hole of 8 mm in which the bacteria or antibiotic substance is placed. The diameter of the inhibition zone around the hole classifies the inhibitory capacity in four grades:

  • Grade 0: no inhibition zone.
  • Grade 1: inhibition zone from 8 to 11 mm.
  • Grade 2: inhibition zone from 11 to 14 mm.
  • Grade 3: inhibition zone more than 14 mm.

The degree of inhibition is proportional to the diameter, then, the product with Grades 2 and 3 in the test are considered optimal to counteract the growth of the pathogen studied.

The following graphs show the results of inhibition of different assays with Megaflora 9 evo, or with the specific strains it contains, on various pathogens.

Megaflora 9 evo has demonstrate to have a high degree inhibiting pathogens belonging to the family Enterobacteriaceae such as E. coli, Shigella, Salmonella and Proteus agglomerans. In all cases, the degree of inhibition was 3 with a value of the inhibition zone over 14 mm.

Growth inhibition of Enterobacteriaceae

In another test, the individual inhibitory capacity of some strains of Megaflora 9 evo on the growth of Candida albicans was evaluated. The results showed different degree of inhibition depending on the strain, being L. plantarum and L. salivarius the most active. L. salivarius, in particular, showed a 100% inhibition of Candida growth. Also, Lactococcus lactis showed good inhibition with a score of more than 80%.

Growth inhibition of Candida albicans

In a third test, it was determined the inhibitory capacity of Clostridium difficile growth at 24 and 48 hours of incubation, as well as the production of toxins A and B. In this case, Enterococcus faecium W54 strain presented the most potent inhibitory capacity, with a significant inhibition of growth at 24h and total at 48h. Other strains, as L. paracasei W20 and L. salivarius W24, present in Megaflora 9 evo also inhibited the total Clostridium growth at 48 h.

Concerning the inhibition of the production of toxins A & B besides of the strains mentioned also Bifidobacrtrium lactis W51 was also able to inhibit totally the production of these enterotoxins.

It is interesting to compare the results of this study with the inhibition of Candida albicans, because it justifies the presence of multispecies and multi-strain in the mixture. While Enterococcus faecium W54 showed no inhibition on candidas but was the most active inhibiting the growth of Clostridium difficile.

Growth inhibition of Clostridium difficile

>> Action at Level 2: influence on the epithelial barrier function

The new generation of probiotics

10 years ago, Solchem Nature S.L. positioned a multispecies and multi-strain probiotic mixture in the market specifically selected for overall health and well-being, which has become one of the best mixtures for different gastrointestinal situations and general health, thanks to its unique properties that clearly distinguish it from any other similar mixture.

In recent years, there has been a continuous research in the field of probiotics about the relationships among gut microbiota, probiotics, prebiotics, health and disease, with the objective to improve Solchem’s multispecies and multi-strain probiotic mixture.

With the objective of increasing the effectiveness of the probiotic-prebiotic mixture, it has been developed a specific technology resulting in a new and improved formulation.

Research has led to an improvement of the existing mixture, which is presented under the name Megaflora 9 evo. This mixture is based in an improved prebiotic matrix containing ingredients specifically selected for their efficacy on the different Megaflora 9 evo bacterial strains, in order they can act at three intestinal levels.

The advantages of a specific technology

Fruit of an innovative research supporting probiotic properties; SOLCHEM NATURE S.L. presents a specific matrix that includes prebiotic ingredients, minerals and enzymes.

The balance of these ingredients in the matrix has been widely studied and the amounts of each ingredient carefully adjusted to suit the needs of the 9 bacterial strains of Megaflora 9 evo. The result is a highly active multispecies probiotics.

Specific prebiotic ingredients for bacterial strains

Prebiotics are food components, primarily carbohydrates and fibre that selectively promotes growth and/or activity of bacteria in the large intestine. Research has shown that each probiotic strain has a specific preference for one type of prebiotic, as shown for example for L. acidophilus.

Growth of different strains of Lactobacillus acidophilus in different prebiotics substrates.
Abbreviations: Polydex (Polydextrose), GOS (Galacto-oligosaccharides), scFOS (Fructo-oligosaccharides short chain)

Vegetable protein

The specific selected ingredients that are part of the matrix makes bacteria of Megaflora 9 evo resistant to the gastric juice action and helps bacteria to reach the intestine in an active state. In this state, bacteria are able to produce lactic acid, short-chain fatty acids and other metabolites.

The matrix provides the nutritional support that bacteria needs to colonize and multiply themselves in the gut, resulting in an even more effective probiotic product.

Among the different ingredients, the presence of a vegetable protein as a prebiotic ingredient in the matrix produces a positive effect on the metabolic activity of the bacteria, mainly in the production of lactic acid.

Lactic acid producing activity favoured by the matrix.

Furthermore, the presence of the vegetable protein facilitates and shortens the rehydration of the product. Ussually, the rehydration of probiotics can take up to 10 minutes, whereas the presence of this vegetable protein shortens it to 1 minute.

In practice, this means that the probiotic formulation may be consumed almost immediately after adding water. The vegetable protein reduces the rehydration time at the same time that shows the highest production of lactic acid.

Impact of the incorporation of the vegetable protein in prebiotic and mineral matrix when rehydrating Megaflora 9 evo.

In summary, the specific technology used in Megaflora 9 evo production includes a special matrix that protects and nourishes the bacteria. These ingredients specifically selected and tested have shown that:

  • Increase the product shelf life.
  • Increase the gastrointestinal bacteria survival.
  • Increase the metabolic activity of lactic acid producing bacteria in the gut.

Megaflora 9 evo: Action at three levels

If something characterizes Megaflora 9 evo as a new generation of probiotics is not only the presence of a special matrix, as has been explained, but a careful selection of bacterial strains.

Megaflora 9 evo contains nine bacterial strains well characterized comprised in 4 different species with a concentration of 2.000.000.000 cfu/g:

  • Bifidobacterium lactis W51
  • Bifidobacterium lactis W52
  • Enterococcus faecium W54
  • Lactobacillus acidophilus W22
  • Lactobacillus paracasei W20
  • Lactobacillus plantarum W1
  • Lactobacillus plantarum W21
  • Lactobacillus salivarius W24
  • Lactococcus lactis W19

These nine strains are integrated into the matrix and have shown efficacy in three levels:

  • Level 1: Inhibition of pathogens.
  • Level 2: keeping barrier function.
  • Level 3: stimulate the production of immunomodulatory cytokines

 

>> Action at Level 1: Inhibition of pathogenic